JAZZ logo

Jazz Pharmaceuticals (JAZZ) return on equity

annual ROE:

14.31%+2.15%(+17.68%)
December 31, 2024

Summary

  • As of today (May 20, 2025), JAZZ annual return on equity is 14.31%, with the most recent change of +2.15% (+17.68%) on December 31, 2024.
  • During the last 3 years, JAZZ annual ROE has risen by +22.96% (+265.43%).
  • JAZZ annual ROE is now -92.79% below its all-time high of 198.47%, reached on December 31, 2008.

Performance

JAZZ ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZprofitability metrics

quarterly ROE:

12.12%-2.27%(-15.77%)
March 1, 2025

Summary

  • As of today (May 20, 2025), JAZZ quarterly return on equity is 12.12%, with the most recent change of -2.27% (-15.77%) on March 1, 2025.
  • Over the past year, JAZZ quarterly ROE has increased by +2.82% (+30.32%).
  • JAZZ quarterly ROE is now -97.46% below its all-time high of 478.08%, reached on December 31, 2008.

Performance

JAZZ quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

JAZZ ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+17.7%+30.3%
3 y3 years+265.4%+204.8%
5 y5 years-19.8%+27.0%

JAZZ ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+265.4%-15.8%+204.8%
5 y5-year-19.8%+265.4%-21.5%+204.8%
alltimeall time-92.8%+105.7%-97.5%+100.6%

JAZZ ROE History

DateAnnualQuarterly
Mar 2025
-
12.12%(-15.8%)
Dec 2024
14.31%(+17.7%)
14.39%(+17.2%)
Sep 2024
-
12.28%(+13.3%)
Jun 2024
-
10.84%(+16.6%)
Mar 2024
-
9.30%(-23.0%)
Dec 2023
12.16%(-291.2%)
12.08%(+389.1%)
Sep 2023
-
2.47%(-190.8%)
Jun 2023
-
-2.72%(-44.4%)
Mar 2023
-
-4.89%(-27.6%)
Dec 2022
-6.36%(-26.5%)
-6.75%(+1150.0%)
Sep 2022
-
-0.54%(-60.9%)
Jun 2022
-
-1.38%(-88.1%)
Mar 2022
-
-11.57%(+36.8%)
Dec 2021
-8.65%(-222.7%)
-8.46%(+98.6%)
Sep 2021
-
-4.26%(-483.8%)
Jun 2021
-
1.11%(-92.8%)
Mar 2021
-
15.44%(+108.4%)
Dec 2020
7.05%(-60.5%)
7.41%(+28.2%)
Sep 2020
-
5.78%(+31.1%)
Jun 2020
-
4.41%(-53.8%)
Mar 2020
-
9.54%(-46.6%)
Dec 2019
17.84%(+9.1%)
17.88%(-14.5%)
Sep 2019
-
20.92%(-8.3%)
Jun 2019
-
22.82%(+33.0%)
Mar 2019
-
17.16%(+8.7%)
Dec 2018
16.35%(-23.1%)
15.79%(-15.7%)
Sep 2018
-
18.74%(+12.6%)
Jun 2018
-
16.64%(-9.6%)
Mar 2018
-
18.40%(-15.2%)
Dec 2017
21.26%(-6.9%)
21.69%(+19.4%)
Sep 2017
-
18.17%(-13.7%)
Jun 2017
-
21.05%(-8.3%)
Mar 2017
-
22.95%(-1.8%)
Dec 2016
22.83%(+2.9%)
23.37%(+5.3%)
Sep 2016
-
22.19%(-2.8%)
Jun 2016
-
22.82%(+2.6%)
Mar 2016
-
22.25%(-1.6%)
Dec 2015
22.19%
22.62%(-3.2%)
Sep 2015
-
23.36%(+18.3%)
DateAnnualQuarterly
Jun 2015
-
19.74%(+16.9%)
Mar 2015
-
16.89%(+279.6%)
Dec 2014
4.38%(-75.5%)
4.45%(+78.0%)
Sep 2014
-
2.50%(-61.7%)
Jun 2014
-
6.53%(0.0%)
Mar 2014
-
6.53%(-63.8%)
Dec 2013
17.90%(-59.2%)
18.03%(-44.3%)
Sep 2013
-
32.35%(+4.9%)
Jun 2013
-
30.85%(-3.0%)
Mar 2013
-
31.82%(-15.9%)
Dec 2012
43.92%(-60.8%)
37.84%(+70.8%)
Sep 2012
-
22.15%(-27.3%)
Jun 2012
-
30.45%(-40.5%)
Mar 2012
-
51.20%(-56.9%)
Dec 2011
111.92%(+4.3%)
118.73%(-32.7%)
Sep 2011
-
176.47%(-59.3%)
Jun 2011
-
433.64%(+102.2%)
Mar 2011
-
214.50%(-219.4%)
Dec 2010
107.29%(+1042.6%)
-179.61%(+577.5%)
Sep 2010
-
-26.51%(-1788.5%)
Jun 2010
-
1.57%(-116.1%)
Mar 2010
-
-9.73%(-219.7%)
Dec 2009
9.39%(-95.3%)
8.13%(-89.6%)
Sep 2009
-
77.90%(-37.0%)
Jun 2009
-
123.70%(-46.8%)
Mar 2009
-
232.64%(-51.3%)
Dec 2008
198.47%(-178.6%)
478.08%(-153.7%)
Sep 2008
-
-889.71%(+172.5%)
Jun 2008
-
-326.45%(+51.1%)
Mar 2008
-
-216.07%(-39.2%)
Dec 2007
-252.45%(-849.3%)
-355.46%(-82.8%)
Sep 2007
-
-2067.86%(+134.3%)
Jun 2007
-
-882.51%(-883.4%)
Mar 2007
-
112.65%(+234.4%)
Dec 2006
33.69%(-53.2%)
33.69%(-41.7%)
Sep 2006
-
57.80%(-11.6%)
Jun 2006
-
65.37%(-10.4%)
Mar 2006
-
72.94%(+1.3%)
Dec 2005
72.01%
72.01%

FAQ

  • What is Jazz Pharmaceuticals annual return on equity?
  • What is the all time high annual ROE for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual ROE year-on-year change?
  • What is Jazz Pharmaceuticals quarterly return on equity?
  • What is the all time high quarterly ROE for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly ROE year-on-year change?

What is Jazz Pharmaceuticals annual return on equity?

The current annual ROE of JAZZ is 14.31%

What is the all time high annual ROE for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual return on equity is 198.47%

What is Jazz Pharmaceuticals annual ROE year-on-year change?

Over the past year, JAZZ annual return on equity has changed by +2.15% (+17.68%)

What is Jazz Pharmaceuticals quarterly return on equity?

The current quarterly ROE of JAZZ is 12.12%

What is the all time high quarterly ROE for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly return on equity is 478.08%

What is Jazz Pharmaceuticals quarterly ROE year-on-year change?

Over the past year, JAZZ quarterly return on equity has changed by +2.82% (+30.32%)
On this page